Takeda says to buy Millennium Pharma for $8.8 billion
TOKYO (Reuters) - Takeda Pharmaceutical Co Ltd said it would buy U.S. firm Millennium Pharmaceuticals Inc for $8.8 billion to boost its cancer drug business, in the biggest overseas acquisition by a Japanese drugmaker.
<p><img src="http://feeds.reuters.com/~a/reuters/businessNews?i=nM9mTv" border="0"></img> (http://feeds.reuters.com/~a/reuters/businessNews?a=nM9mTv)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/reuters/businessNews?i=UtsnQzG" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=UtsnQzG) <img src="http://feeds.reuters.com/~f/reuters/businessNews?i=mqo8uIg" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=mqo8uIg) <img src="http://feeds.reuters.com/~f/reuters/businessNews?i=KHjPUrg" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=KHjPUrg)
</div><img src="http://feeds.reuters.com/~r/reuters/businessNews/~4/267533323" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/businessNews/~3/267533323/idUST18218420080410